General form of registration statement for all companies including face-amount certificate companies

Stockholders' Deficit (Details Narrative)

v3.20.1
Stockholders' Deficit (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Sep. 10, 2019
Jul. 19, 2019
Jun. 24, 2019
Apr. 14, 2016
May 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Jan. 02, 2020
Aug. 31, 2019
Sep. 21, 2018
Sep. 20, 2018
Jan. 23, 2018
Jan. 22, 2018
Dec. 09, 2014
Reverse stock split     one-for-five hundred (1:500)                          
Common stock, par value     $ 0.001     $ 0.001   $ 0.001 $ 0.001              
Common stock, shares authorized     100,000,000     100,000,000   100,000,000 100,000,000     4,000,000,000 400,000,000 400,000,000 100,000,000  
Preferred stock, shares authorized           1,500,005   1,500,005 1,500,005             500,000
Preferred stock, par value           $ 0.01   $ 0.01 $ 0.01              
Common stock issued during period   20,000       1,246,859                    
Debt conversion price per share                   $ 0.165            
Conversion price, decrease           $ 0.067                    
Conversion price, increase           $ 0.906                    
Conversion of principal and interest, aggregate amount           $ 318,768                    
Additional paid in capital           47,766,162   $ 45,713,322 $ 38,214,213 $ 410,750            
Embedded derivative liability           $ 924,744   698,264 371,532              
Common stock reserved for future issuances           77,292,139                    
Share issued price per share   $ 1.99                            
Proceeds from issuance of common stock   $ 39,800       $ 405,773 1,100,380              
Consulting expenses           39,800                    
Number of restricted shares issued         78,000                      
Share based compensation arrangement by share based payment award options grant date fair value       $ 3,924,880                        
Share Based Compensation           $ 150,208              
Warrants to purchase common stock 1,000,000                              
Warrant exercise price $ 2.00                              
Warrant expiration date Sep. 10, 2022                              
Fair value of warrants $ 984,810                              
Share-based Payment Arrangement, Option [Member]                                
Granted exercise price           $ 76.37                    
Share Based Compensation         $ 41,437                      
Grant options to purchase           59,644                    
Exercise price         $ 4.65                      
Risk free rate         2.42%                      
Dividend yield         0.00%                      
Fair value term         10 years                      
Expected volatility         268.00%                      
Option granted value         $ 248,620                      
Common Stock [Member]                                
Amount recorded to equity           $ 343,179                    
Embedded conversion option derivatives           46,600                    
Fair market value of shares issued value           71,011                    
Loss on extinguishment           24,411                    
Gain on extinguishment           44,587                    
Additional paid in capital           160,205                    
First Warrant [Member]                                
Warrants to purchase common stock                     450,000          
Warrant exercise price                     $ 2.25          
Second Warrant [Member]                                
Warrants to purchase common stock                     300,000          
Warrant exercise price                     $ 3.33          
Third Warrant [Member]                                
Warrants to purchase common stock                     225,000          
Warrant exercise price                     $ 4.50          
Warrant [Member]                                
Share Based Compensation           $ 984,810                    
Warrants outstanding and exercisable           1,975,059                    
Warrants expiration term description           As of December 31, 2019, there were 1,975,059 warrants outstanding and exercisable with expiration dates commencing May 2020 and continuing through August 2024, with a weighted average exercise price per share of $2.69.   Expiration dates commencing May 2020 and continuing through November 2020                
Restricted Stock Units (RSUs) [Member]                                
Number of restricted shares issued         117,000                      
Granted exercise price         $ 4.25                      
Share based compensation arrangement by share based payment award options grant date fair value         $ 497,240                      
Share Based Compensation           $ 108,771                    
Unrecognized restricted stock units expense           357,392                    
Restricted Stock [Member]                                
Unvested stock option recognized           $ 196,824                    
Chief Executive Officer [Member]                                
Common stock issued during period         58,500                      
Number of restricted shares issued         39,000                      
Granted exercise price       $ 3,750                        
Share based compensation arrangement by share based payment award options grant date fair value       $ 1,962,440                        
Grant options to purchase       572                        
Option Description         The total 58,500 options have a term of 10 years from the date of grant and exercise price ranging from $4.25 to $4.675 per share. 1/3rd of these options shall vest every successive one-year anniversary, provided, that on each such vesting date, the Chief Executive Officer and Chief Scientific Officer are employed by the Company and subject to the other provisions of the employment agreement. The 58,500 stock options were valued using a Black-Scholes model with the following assumptions: stock price at valuation date of $4.25 based on quoted trading price on date of grant, exercise price of $4.65, dividend yield of zero, years to maturity of 10.00, a risk free rate of 2.42%, and expected volatility 268% for a total value of $248,620.                      
Chief Executive Officer [Member] | Share-based Payment Arrangement, Option [Member]                                
Grant options to purchase         39,000                      
Chief Scientific Officer [Member] | Share-based Payment Arrangement, Option [Member]                                
Grant options to purchase         19,500                      
Convertible Debt [Member]                                
Debt conversion price per share           $ 0.3575                    
Embedded derivative liability           $ 343,179                    
Fair market value of shares           $ 343,179                    
Series A Preferred Stock [Member]                                
Preferred stock, shares authorized           500,000   500,000 500,000             500,000
Preferred stock, par value           $ 0.01   $ 0.01 $ 0.01              
Preferred stock, shares issued           500,000   500,000 500,000              
Preferred stock, shares outstanding           500,000   500,000 500,000